Aria Diagnostics (fka Tandem Diagnostics) is a privately funded biotechnology company based on a strong, scientific foundation. Their novel blood tests equip pregnant women with the right information to make decisions regarding the health of their baby and their own body.

• Head of Marketing

BioTime, Inc. (NYSE AMEX: BTIM) is a biotechnology company headquartered in Alameda, California. Their biomedical research and product development focuses on stem cell technology and products for use in regenerative medicine, as well as blood plasma volume expanders and related technology.

• Chief Financial Officer

Founded by leading researchers in the field of nucleic acid analysis methods from the University of British Columbia, Boreal Genomics develops and commercializes high performance methods and instruments revolutionizing nucleic acid purification and enrichment for life science research, forensics and clinical diagnostics.

• Chief Executive Officer

Based in Cleveland, Ohio, the Gebauer Company is an internationally recognized medical device manufacturer dedicated to providing Patient Comfort Solutions™to the healthcare industry through the development and production of affordable, easy-to-use medical devices. Their core products include Gebauer's Ethyl Chloride®, Gebauer's Pain Ease®, Gebauer's Spray and Stretch® and Gebauer's Instant Ice®.

• Vice President of Sales and Marketing

MTS Medication Technologies is an international provider of adherence packaging systems designed to improve medication management, dispensing and administration. MTS manufactures a full suite of innovative proprietary equipment and related consumables for prescription medications and nutritional supplements, serving approximately 9,000 pharmacies worldwide.

• Senior Vice President of Product Development

Nabsys is a life sciences company working at the intersection of physics, biology and computer science to revolutionize medicine through clinical-grade whole-genome DNA sequencing.

• Vice President of Semiconductor Operations

Founded in 2008, Sequenta, Inc. (fka MLC Dx, Inc.) is a privately held company developing and commercializing molecular diagnostic assays based on proprietary sequencing approach to the profiling of T and B cell receptor repertoires. Sequenta's investors include Mohr Davidow and Index Ventures.

• Vice President of Marketing